
Granules India Ltd is Rated Hold by MarketsMOJO
2026-11-13 10:12:22Granules India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 13 November 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read More
Granules India Ltd is Rated Hold by MarketsMOJO
2026-11-01 10:10:46Granules India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Granules India Ltd Valuation Shifts to Very Expensive Amid Strong Returns
2026-10-28 08:00:29Granules India Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen its valuation metrics shift markedly, moving from an expensive to a very expensive territory. Despite this, the company continues to deliver robust returns, outperforming the Sensex significantly over multiple time horizons. This article analyses the recent valuation changes, compares them with historical and peer averages, and assesses the implications for investors.
Read More
Granules India Ltd is Rated Hold by MarketsMOJO
2026-10-21 10:10:56Granules India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 October 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read More
Granules India Ltd is Rated Hold by MarketsMOJO
2026-10-10 10:10:35Granules India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 October 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Granules India Ltd Valuation Shifts Amidst Market Volatility
2026-10-05 08:01:51Granules India Ltd has witnessed a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, reflecting a subtle decline in price attractiveness. This change comes amid a backdrop of strong stock returns and evolving sector dynamics, prompting investors to reassess the pharmaceutical company's relative value against peers and historical benchmarks.
Read MoreGranules India Ltd Falls 5.80%: Mixed Technical Signals and Market Volatility Shape the Week
2026-10-03 17:00:04Key Events This Week 28 Sep: Technical momentum signals bullish outlook despite market weakness 29 Sep: Downgrade to Hold amid mixed technical and valuation signals 30 Sep: Technical momentum shifts back to bullish amid market volatility 1 Oct: Mildly bullish technical stance amid consolidation and price decline Week OpenRs.871.35 <div class="stat...
Read More
Granules India Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-10-01 08:02:12Granules India Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflected in a downgrade of its Mojo Grade from Buy to Hold as of 28 Sep 2026. Despite a strong year-to-date return of 41.6%, the stock’s recent price action and technical indicators suggest a cautious outlook for investors navigating the evolving market dynamics.
Read More
Granules India Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Market Volatility
2026-09-30 08:02:30Granules India Ltd has exhibited a notable shift in technical momentum, transitioning from a mildly bullish to a bullish trend, supported by key indicators such as moving averages and Bollinger Bands. Despite mixed signals from weekly MACD and KST, the monthly technicals and price action suggest a strengthening outlook for this small-cap pharmaceutical player.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
10-Nov-2026 | Source : BSESchedule of Investor Meet
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
06-Nov-2026 | Source : BSETranscript of the Earnings Conference Call for Q2 and the half year of FY27
Change In Corporate Office Address Of Registrar And Share Transfer Agent
06-Nov-2026 | Source : BSEChange in Corporate Office Address of Registrar and Share Transfer Agent (RTA)
Corporate Actions
No Upcoming Board Meetings
Granules India Ltd has declared 175% dividend, ex-date: 30 Jul 26
Granules India Ltd has announced 1:10 stock split, ex-date: 23 Mar 15
No Bonus history available
No Rights history available